OR WAIT null SECS
March 02, 2017
Effective solutions for overcoming the high molecular weight, hydrophilicity, and instability of large biomolecules have yet to be identified.
February 27, 2017
Sanofi and Lonza formed a joint venture to build and operate a large-scale mammalian cell culture facility for monoclonal antibody production in Visp, Switzerland.
February 01, 2017
FDA issued approvals for less than half the number of new drugs in 2016 compared with 2015.
January 13, 2017
New website allows access to research quantities of commercial-grade ligands and catalysts.
January 04, 2017
Alternatives to expensive palladium catalysts are gaining acceptance for commercial API synthesis.
January 02, 2017
As of mid-December, less than half the number of new drug approvals were issued by FDA in 2016 compared with 2015.
December 21, 2016
AGC adds second biopharma contract manufacturer with acquisition of CMC Biologics.
December 09, 2016
Saneca Pharma has received a EUR1.5 million grant from the Slovak Ministry of Education, Science, Research, and Sport, which will be used to drive forward new R&D initiatives for API manufacturing.
December 07, 2016
Previous hesitation by pharma industry to use cocrystals may change with FDA’s new guidance that classifies cocrystals APIs.
December 02, 2016
Non-precious-metal catalysts are increasingly employed for commercial API synthesis.